baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BNP Paribas Discount Zert ABBV 29.../ DE000PC1Q012 /

2024-06-11 12:20:22 PM	Chg.+0.130	Bid1:04:03 PM	Ask1:04:03 PM	Underlying	Strike price	Expiration date	Option type
128.250EUR	+0.10%	128.310 Bid Size: 151	128.410 Ask Size: 151	AbbVie Inc	- USD	2025-12-29	Call

GlobeNewswire 12:28 PM CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Urg...

GlobeNewswire 06-08 CEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into ...

GlobeNewswire 06-05 CEREVEL INVESTIGATION ALERT: Cerevel (Nasdaq: CERE) Investors are Encouraged to Contact BFA Law abou...

GlobeNewswire 06-05 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

GlobeNewswire 06-05 OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR...

GlobeNewswire 06-04 Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 06-04 BioVie Announces Formation of Advisory Board for Bezisterim in Long COVID

GlobeNewswire 06-03 Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes

GlobeNewswire 06-03 ACQUISITION NEWS: Cerevel’s (Nasdaq: CERE) $45 Merger Offer is Being Investigated for Being Too Low,...

GlobeNewswire 06-01 CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation ...

GlobeNewswire 05-30 OSE Immunotherapeutics Provides Business and Corporate Update

GlobeNewswire 05-29 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 05-28 Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Imp...

GlobeNewswire 05-28 CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...

GlobeNewswire 05-28 Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million

GlobeNewswire 05-25 CERE (NASDAQ) ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation; Contact BFA Law ...

GlobeNewswire 05-24 Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7...

GlobeNewswire 05-23 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...

GlobeNewswire 05-22 Over 130 Resident Dermatologists Receive In-Depth Cosmetic Training From Renowned ASDS Member Physic...

GlobeNewswire 05-22 Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $57...

GlobeNewswire 05-22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 05-22 Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $57...

GlobeNewswire 05-22 Anavex Life Sciences Announces Expansion of Leadership Team

GlobeNewswire 05-22 OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treat...

GlobeNewswire 05-21 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer

BNP Paribas Discount Zert ABBV 29.../ DE000PC1Q012 /

If you wish to receive reply to your feedback, please provide your email address.